RKDA
Arcadia Biosciences·NASDAQ
--
--(--)
--
--(--)
6.75 / 10
Outperform
Fund-flow sentiment is positive yet not overwhelming at 6.75/10. Medium-sized inflows show a positive trend, but block, large, and extra-large orders lean negative, hinting at institutional hesitation. This mixed flow aligns with the stock's overall Outperform rating but underscores volatility as larger players appear cautious.
Fund Flow Rating
What is the analyst consensus for RKDA?
- RKDA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.75/10 (Outperform).
